GlassScriptPhysician profile
Markus P Wrobel
NPI 1669093928
$570.94
in general payments reported to CMS, 2019-2025
16 companies · $442 in 2025
The $442 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.39 · 2024: $111 · 2025: $442.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $124.99 | 2025 | Evenity |
| Novo Nordisk INC | $62.25 | 2024-2025 | Wegovy |
| Viiv Healthcare Company | $55.48 | 2025 | Apretude |
| Gilead Sciences, INC. | $51.32 | 2025 | |
| Exact Sciences Corporation | $46.69 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $44.16 | 2025 | |
| Abbvie INC. | $26.44 | 2025 | |
| Noven Therapeutics, LLC | $23.98 | 2025 | Xelstrym |
| Rgh Enterprises LLC | $19.54 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.17 | 2025 | Xifaxan |
| Tris Pharma INC | $17.94 | 2024 | Dyanavel Xr |
| Radius Health, INC. | $17.58 | 2025 | Tymlos |
| Axsome Therapeutics, INC. | $17.39 | 2023 | Auvelity |
| Antares Pharma, INC. | $16.92 | 2024 | Xyosted |
| Astrazeneca Pharmaceuticals LP | $14.94 | 2025 | Breztri |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $13.15 | 2024 | Aplenzin, Wellbutrin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Markus Wrobel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.